A comparison between PTFE and denatured homologous vein grafts for haemodialysis access: a prospective randomised multicentre trial
- 31 August 1998
- journal article
- clinical trial
- Published by Elsevier BV in European Journal of Vascular and Endovascular Surgery
- Vol. 16 (2), 126-132
- https://doi.org/10.1016/s1078-5884(98)80153-6
Abstract
Objectives:To compare patency and complication rates of polytetrafluoroethylene (PTFE) grafts and denatured homologous vein (DHV) grafts for long-term haemodialysis.Design:A prospective randomised multicentre trial.Materials:One hundred and thirty-one patients were enrolled between September 1994 and April 1997. Sixty-three DHV grafts and 68 PTFE grafts were implanted in 60 males and 71 females. Complications and interventions were monitored. Patency rates, complication rates, and intervention rates of PTFE and DHV were compared.Results:The mean follow-up was 313 days for DHV (range 1–771) and 339 (3–909) days for PTFE. The total follow-up was 54.1 patient-years for DHV and 63.1 for PTFE. The 1-year primary patency rates were 30% and 40% for DHV and PTFE respectively. Secondary patency rate was 63% for both DHV and PTFE. Most frequent complication was thrombosis. A total of 75 thrombotic events (1.39 per patient-year) occurred in 35 (56%) DHV grafts and 78 (1.24 per py) in 36 (53%) PTFE grafts. A total of nine infections were seen in nine (14%) DHV grafts, whereas 21 infections in 20 (29%) PTFE grafts were seen (p=0.08). All but one infected DHV graft could be salvaged with systemic antibiotics. In contrast, surgical intervention was necessary in nine PTFE grafts (p = 0.02). For aneurysms, eight DHV and two PTFE grafts needed revision (p = 0.03).Conclusion:Patency rates between DHV and PTFE were not different. More infections were seen in PTFE grafts, and significantly more PTFE grafts needed surgical revision or removal because of infection. Significantly more DHV grafts were surgically revised or removed because of aneurysmsKeywords
This publication has 25 references indexed in Scilit:
- A Preliminary Experience with the Human Homologous Vein Graft for Vascular AccessVascular Surgery, 1996
- The results of denatured homologous vein grafts as conduits for secondary haemodialysis access surgeryEuropean Journal of Vascular and Endovascular Surgery, 1995
- Predictive value of colour Doppler ultrasonography in detecting failure of vascular access graftsBritish Journal of Surgery, 1995
- Mechanical versus pharmacomechanical thrombolysis for the treatment of thrombosed dialysis access graftsKidney International, 1994
- The Effect of Doppler Flow Screening Studies and Elective Revisions on Dialysis Access FailureASAIO Journal, 1992
- Prevention of hemodialysis fistula thrombosis. Early detection of venous stenosesKidney International, 1989
- Staphylococcus aureusNasal Carriage and Infection in Patients on HemodialysisNew England Journal of Medicine, 1986
- Vascular Access for Hemodialysis Patency Rates and Results of RevisionAnnals of Surgery, 1985
- POLYTETRAFLUOROETHYLENE (PTFE) GRAFTS FOR HAEMODIALYSIS: PATENCY AND COMPLICATIONS COMPARED WITH THOSE OF SAPHENOUS VEIN GRAFTSAnz Journal of Surgery, 1979
- Prevention of Thrombosis in Patients on Hemodialysis by Low-Dose AspirinNew England Journal of Medicine, 1979